These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28552224)

  • 1. From evidence-based medicine to personalized medicine, with particular emphasis on drug-safety monitoring.
    Ennezat PV; Cosgrove S; Bouvaist H; Maréchaux S; Guerbaai RA; Le Jemtel T; Andréjak M; Vital-Durand D
    Arch Cardiovasc Dis; 2017; 110(6-7):413-419. PubMed ID: 28552224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trials and observational studies in the assessment of drug safety.
    Sawchik J; Hamdani J; Vanhaeverbeek M
    Rev Epidemiol Sante Publique; 2018 May; 66(3):217-225. PubMed ID: 29685700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety assessment in clinical trials: methodological challenges and opportunities.
    Singh S; Loke YK
    Trials; 2012 Aug; 13():138. PubMed ID: 22906139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How I explore ... a risk difference in the occurrence of an event in clinical trials].
    Scheen AJ; Ernest P; Jandrain B
    Rev Med Liege; 2012 Nov; 67(11):597-602. PubMed ID: 23346831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal-related events in metastatic prostate cancer and the number needed to treat: a critical consideration.
    Schmitz-Dräger BJ; Weiss C; Ebert T; Dörsam J; Bismarck E
    Urol Int; 2013; 90(3):329-33. PubMed ID: 23407093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The credibility of the FDA.
    Blankfield RP
    Eur J Prev Cardiol; 2013 Dec; 20(6):992-4. PubMed ID: 23867140
    [No Abstract]   [Full Text] [Related]  

  • 10. Smoke and mirrors: Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosis.
    Zakaria M
    Mult Scler Relat Disord; 2015 May; 4(3):187-91. PubMed ID: 26008935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring liver safety in drug development: the GSK experience.
    Hunt CM; Papay JI; Edwards RI; Theodore D; Alpers DH; Dollery C; Debruin TW; Adkison KK; Stirnadel HA; Gibbs TG
    Regul Toxicol Pharmacol; 2007 Nov; 49(2):90-100. PubMed ID: 17655994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
    Citrome L
    Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons.
    Mendes D; Alves C; Batel Marques F
    Expert Opin Drug Saf; 2016 Oct; 15(10):1301-12. PubMed ID: 27467204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.
    Irving E; van den Bor R; Welsing P; Walsh V; Alfonso-Cristancho R; Harvey C; Garman N; Grobbee DE;
    J Clin Epidemiol; 2017 Nov; 91():6-12. PubMed ID: 28502812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.
    van der Goes MC; Jacobs JW; Boers M; Andrews T; Blom-Bakkers MA; Buttgereit F; Caeyers N; Cutolo M; Da Silva JA; Guillevin L; Kirwan JR; Rovensky J; Severijns G; Webber S; Westhovens R; Bijlsma JW
    Ann Rheum Dis; 2010 Nov; 69(11):1913-9. PubMed ID: 20693273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison and analysis of clinical safety evaluation methods for parenterally administered Chinese medicine].
    Yan BH; Peng C; Xie YM; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2979-82. PubMed ID: 24471315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions.
    Mayne TJ; Whalen E; Vu A
    J Clin Epidemiol; 2006 Mar; 59(3):217-23. PubMed ID: 16488351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine based evidence and personalized care of patients.
    Horwitz RI; Charlson ME; Singer BH
    Eur J Clin Invest; 2018 Jul; 48(7):e12945. PubMed ID: 29700817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects.
    van der Leeuw J; Ridker PM; van der Graaf Y; Visseren FL
    Eur Heart J; 2014 Apr; 35(13):837-43. PubMed ID: 24513790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.